eli lilly and company retatrutide shares safety, tolerability data on its next-gen obesity drug Investigating the “efficacy and safety

Good news: You can technically try em allespecially since rotating your injection site is recommended

This collaboration pairs Vivanis NanoPortal slow-release delivery platform with Okavas veterinary metabolic-health focus, aiming for a six-month One-and-Done GLP-1 treatment for obesity, diabetes, and aging-related metabolic decline

Its not just I want to feel good, but I actually want to look a certain way too, which is a bit of a rebound from where weve been in recent years [where brands in the weight management space have markedly shifted their marketing from dieting and weight loss to wellness and weight management].

In this article, Ive synthesized both into a single, clinician-friendly algorithm, highlighting where they agree, where they differ, and whats genuinely new